Tyrosine kinase inhibitor
CAS No. 1021950-26-4
Tyrosine kinase inhibitor ( —— )
产品货号. M26856 CAS No. 1021950-26-4
酪氨酸激酶抑制剂是一种酪氨酸激酶抑制剂,与片段化芳香族氮化合物联合用作抗增殖剂。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ¥1492 | 有现货 |
|
| 5MG | ¥2527 | 有现货 |
|
| 10MG | ¥3772 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ¥3259 | 有现货 |
|
生物学信息
-
产品名称Tyrosine kinase inhibitor
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述酪氨酸激酶抑制剂是一种酪氨酸激酶抑制剂,与片段化芳香族氮化合物联合用作抗增殖剂。
-
产品描述Tyrosine kinase inhibitor is a tyrosine kinase inhibitor used in combination with fragmenting aromatic nitrogen compounds as antiproliferative agents.(In Vitro):Tyrosine kinases are important mediators of the signaling cascade, determining key roles in diverse biological processes like growth, differentiation, metabolism and apoptosis in response to external and internal stimuli. Recent advances have implicated the role of tyrosine kinases in the pathophysiology of cancer. Though their activity is tightly regulated in normal cells, they may acquire transforming functions due to mutation(s), overexpression and autocrine paracrine stimulation, leading to malignancy. Constitutive oncogenic activation in cancer cells can be blocked by selective tyrosine kinase inhibitors and thus considered as a promising approach for innovative genome based therapeutics.
-
体外实验Tyrosine kinases are important mediators of the signaling cascade, determining key roles in diverse biological processes like growth, differentiation, metabolism and apoptosis in response to external and internal stimuli.
-
体内实验——
-
同义词——
-
通路Angiogenesis
-
靶点c-Met/HGFR
-
受体Reactive Oxygen Species
-
研究领域——
-
适应症——
化学信息
-
CAS Number1021950-26-4
-
分子量586.624
-
分子式C31H31FN6O5
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : ≥ 46 mg/mL (78.42 mM)
-
SMILESFc1ccc(NC(=O)C2(CC2)C(=O)Nc2ccc(Oc3ccnc4[nH]c(cc34)C(=O)NCCN3CCOCC3)cc2)cc1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Suparna Qanungo, et al. N-Acetyl-L-cysteine Enhances Apoptosis Through Inhibition of Nuclear factor-kappaB in Hypoxic Murine Embryonic Fibroblasts. J Biol Chem
产品手册
关联产品
-
JNJ-38877618
JNJ-38877618 (OMO-1) 是一种新型强效、高选择性、口服生物可利用的 c-Met 酪氨酸激酶抑制剂。
-
Onartuzumab
Onartuzumab (MetMAb) 是一种人源化亲和成熟的单价单克隆抗体,抑制受体酪氨酸激酶 MET。Onartuzumab 可有效抑制 HGF 结合、受体磷酸化和信号转导。Onartuzumab 具有抗体样药代动力学和抗肿瘤活性。
-
TAE226
NVP-TAE226 是一种有效的 FAK 抑制剂,IC50 为 5.5 nM,对 Pyk2 具有中等效力(IC50=3.5 nM);对抗 InsR、IGF-1R、ALK 和 c-Met 的效力低 10 至 100 倍。
021-51111890
购物车()
sales@molnova.cn

